$DXC

DXC’s (NYSE:DXC) Q2 CY2026 Earnings Results: Non

IT services provider DXC Technology (NYSE: DXC) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 5.1% year on year to $3.00 billion. On the other hand, next quarter’s revenue guidance of $2.99 billion was less impressive, coming in 1.5% below analysts’ estimates. Its non-GAAP profit of $0.40 per share was 11.3% below analysts’ consensus estimates. Is now the time to buy DXC? Find out by accessing our full research report, it’s free.

Original reporting
Published Jul 30, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 10:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
DXC’s (NYSE:DXC) Q2 CY2026 Earnings Results: Non — source image
Decision brief

The 30-second read

$DXCBearishMed
01

Why it matters

Near-term trading focus is on the combination of YoY revenue decline, next-quarter revenue guidance below estimates, and adjusted EPS of $0.40 missing consensus, despite in-line revenue and stable adjusted operating margin.

02

Market read

This is a company-specific earnings and guidance update with explicit misses versus analysts, and it is tied to an immediate post-results stock drop.

03

What to watch

The article emphasizes revenue decline and EPS miss, but it also states full-year guidance is maintained; traders may want to separate near-term guidance weakness from the durability of full-year targets.

Relevance 8/10Novelty 8/10Timing: after-hours/next-session reaction to Q2 results and next-quarter guidance (published 2026-07-30)

Background

DXC Technology, an IT services provider, reported Q2 CY2026 results and issued next-quarter revenue guidance alongside adjusted EPS performance versus consensus.

Company-level read

Ticker impact

$DXCBearishMedium confidence
Context

DXC reported Q2 CY2026 revenue of $3.00B (down 5.1% YoY) and guided next-quarter revenue to $2.99B, below estimates, with adjusted EPS $0.40 missing consensus.

Expected impact

Bearish bias for near-term trading, with follow-through risk if investors focus on the revenue and EPS misses versus the in-line revenue beat.

Evidence & confidence

The article provides concrete Q2 results (revenue decline, EPS miss) plus next-quarter revenue and EPS guidance that are described as below analysts’ estimates, and notes the stock fell 5.2% immediately after results.

Market effects

Reinforces a cautious read-through for IT services demand and margin stability, with investors likely to scrutinize guidance more than in-line revenue prints.

No specific regional demand signal beyond general US-listed IT services sentiment.

Limited; the disclosed facts are company-specific and do not indicate a broader global IT services shock.

Counterpoint

DXC maintained full-year guidance and showed stable adjusted operating margin (7.5% in Q2), which could limit downside if investors believe cost discipline offsets revenue softness.

Key entities

  • DXC Technology

    Reported Q2 CY2026 revenue of $3.00B (down 5.1% YoY), adjusted EPS of $0.40 (below consensus), and next-quarter revenue guidance of $2.99B (below estimates).

Related articles

$KDLow

Q2 Rundown: Kyndryl (NYSE:KD) Vs Other IT Services & Consulting Stocks

Kyndryl (KD) reported Q2 revenue of $3.62B, down 3.3% YoY, missing estimates by 0.7% but beating EPS. Gartner (IT) reported $1.68B revenue, up 1.8% YoY, beating estimates. Accenture (ACN) reported $18.72B revenue, up 5.6% YoY, in line with estimates but missed guidance. IBM (IBM) reported $17.16B revenue, up 1.1% YoY, missing estimates by 1.5%. DXC (DXC) reported $3.00B revenue, down 5.1% YoY, in line with estimates but missed EPS.

$DXCMed

IT Services & Consulting Stocks Q2 Results: Benchmarking DXC (NYSE:DXC)

DXC (NYSE:DXC) reported Q2 revenue of $3.00B, down 5.1% YoY, in line with expectations but missing EPS estimates. CEO Fernandez maintained full-year guidance. Gartner (NYSE:IT) reported $1.68B revenue, up 1.8% YoY, beating estimates. Accenture (NYSE:ACN) reported $18.72B revenue, up 5.6% YoY, with weak guidance. Everforth (NYSE:EFOR) reported $1.01B revenue, down 1.3% YoY, beating estimates. Kyndryl (NYSE:KD) reported $3.62B revenue, down 3.3% YoY, missing estimates. IT services stocks are up 5.

$DXCMedAI 8/10

DXC (DXC) Q1 2027 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Roger Sachs President and Chief Executive Officer - Raul J. Fernandez Chief Financial Officer - Robert F. Del Bene TAKEAWAYS Total Revenue -- $3 billion, representing a 6.7% organic decline year over year. Adjusted EBIT Margin -- 5.0%, a decrease of 180 basis points year over year reflecting the anticipated revenue profile and seasonal factors.

$DXCMedAI 9/10

DXC Technology Co (DXC): Results of Operations and Financial Condition

DXC Technology Co (DXC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 DXC Technology Reports First Quarter Fiscal Year 2027 Results • Total revenue for Q1 FY27 of $3.00 billion, down 5.1% YoY, down 6.7% on an organic basis (1) • Q1 FY27 Bookings of $3.0 billion, up 5% YoY with a book to bill ratio of 0.99x • Q1 FY27 EBIT margin of 6.9%